Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Condition(s):COVID-19Last Updated:February 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:February 8, 2023Completed
Condition(s):VaricoceleLast Updated:January 11, 2018Completed
Condition(s):Human Papilloma Virus; Hiv; Organ TransplantsLast Updated:December 11, 2020Completed
Condition(s):COVID-19Last Updated:August 11, 2022Suspended
Condition(s):COVID-19Last Updated:February 17, 2021Unknown status
Condition(s):HealthyLast Updated:November 18, 2023Completed
Condition(s):Chickenpox; ZosterLast Updated:September 12, 2012Completed
Condition(s):PoliomyelitisLast Updated:March 13, 2024Active, not recruiting
Condition(s):COVID-19Last Updated:October 11, 2023Completed
Condition(s):Cervical CancerLast Updated:September 27, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.